Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2021

Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis

Ehab Ghazy
  • Fonction : Auteur
Tino Heimburg
Julien Lancelot
Patrik Zeyen
  • Fonction : Auteur
Karin Schmidtkunz
  • Fonction : Auteur
Anne Truhn
  • Fonction : Auteur
Salma Darwish
  • Fonction : Auteur
Conrad V Simoben
Tajith B Shaik
Frank Erdmann
Matthias Schmidt
  • Fonction : Auteur
Dina Robaa
  • Fonction : Auteur
Manfred Jung
  • Fonction : Auteur
Raymond Pierce
Ray Pierce
  • Fonction : Auteur
Wolfgang Sippl

Résumé

Schistosomiasis is a major neglected parasitic disease that affects more than 265 million people worldwide and for which the control strategy consists of mass treatment with the only available drug, praziquantel. In this study, we chemically optimized our previously reported benzhydroxamate-based inhibitors of Schistosoma mansoni histone deacetylase 8 (smHDAC8). Crystallographic analysis provided insights into the inhibition mode of smHDAC8 activity by the highly potent inhibitor 5o. Structure-based optimization of the novel inhibitors was carried out using the available crystal structures as well as docking studies on smHDAC8. The compounds were evaluated in screens for inhibitory activity against schistosome and human HDACs (hHDAC). The in vitro and docking results were used for detailed structure activity relationships. The synthesized compounds were further investigated for their lethality against the schistosome larval stage using a fluorescence-based assay. The most promising inhibitor 5o showed significant dose-dependent killing of the schistosome larvae and markedly impaired egg laying of adult worm pairs maintained in culture.
Fichier principal
Vignette du fichier
EJMC_smHDAC8_2021.pdf (2.32 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03504304 , version 1 (29-12-2021)

Identifiants

Citer

Ehab Ghazy, Tino Heimburg, Julien Lancelot, Patrik Zeyen, Karin Schmidtkunz, et al.. Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis. European Journal of Medicinal Chemistry, 2021, 225, pp.113745. ⟨10.1016/j.ejmech.2021.113745⟩. ⟨hal-03504304⟩
8 Consultations
98 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More